EN PL
REVIEW PAPER
Eosinophilia in Churg-Strauss syndrome
 
More details
Hide details
 
Online publication date: 2010-04-08
 
 
Reumatologia 2009;47(6):372-375
 
KEYWORDS
ABSTRACT
The main symptoms of Churg-Strauss syndrome (CSS) are asthma, eosinophilia and systemic small and medium-sized vasculitis. Among 59 of our patients with systemic connective tissue diseases and eosinophilia Churg-Strauss syndrome was diagnosed in 30. Increased level of eosinophils in patients with uncertain diagnosis should be a signal of possible Churg-Strauss syndrome for every rheumatologist. The importance of eosinophilia in diagnosis and early treatment of Churg-Strauss syndrome is stressed.
 
REFERENCES (20)
1.
Guillevin L, Pagnoux C. Treatment of ANCA-associated vascularitides. Presse Med 2007; 36: 922-927. .
 
2.
Guillevin L, Pagnoux C, Guilpain P, et al. Indications for biotherapy in systemic vasculitides. Clin Rev Allergy Immunol 2007; 32: 85-96. .
 
3.
Pepper RJ, Fabre MA, Pavesio C, et al. Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production. Rheumatology 2008; 47: 1104-1105. .
 
4.
Garcia G. Allergy-related hypereosinophilia. Presse Med 2006; 35: 135-143. .
 
5.
Hellmich B, Csernok E, Gross WL. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome. Ann NY Acad Sci 2005; 1051: 121-131. .
 
6.
Gleich GJ. Mechanisms of esinophil-associated inflammation. J Allergy Clin Immunol 2000; 105: 651-663. .
 
7.
Simon D, Simon HU. Eosinophilic disorders. J Allergy Clin Immunol 2007; 119: 1291-300. .
 
8.
Czarnobilska E, Olejarz P, Obtulowicz K. Rola eozynofila w chorobach alergicznych i niealergicznych. Alergologia/Immunologia 2007; 4: P53-57. .
 
9.
Fletcher S, Bain B. Diagnosis and treatment of hypereosinophilic syndromes. Curr Opin Hematol 2007; 14: 37-42. .
 
10.
Lotfi R, Lotze MT. Eosinophils induce DC maturation, regulating immunity. J Leukoc Biol 2008; 3: 456-460. .
 
11.
Polzer K, Karonitsch T, Zwerina J. Eotaxin-3 is involved in Churg-Strauss syndrome – a serum marker closely correlating with disease activity. Rheumatology (Oxford) 2008; 47: 804-808. .
 
12.
Fan GK, Wang H, Takenaka H. Eosinophil infiltration and activation in nasal polyposis. Acta Otolaryngol 2007; 127: 521-526. .
 
13.
Gotlib J, Cross NC, Gilliland DG. Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy. Best Pract Res Clin Haematol 2006; 19: 535-569. .
 
14.
Osei-Kumah A, Smith R, Clifton VL. Maternal and cord plasma cytokine and chemokine profile in pregnancies complicated by asthma. Cytokine 2008; 43: 187-193. .
 
15.
Fisher K, Smith S, Skinner R. Cutaneous Churg-Strauss granuloma in a child. J Cutan Pathol 2009; 36: 910-912. .
 
16.
Rosenberg HF, Phipps S, Foster PS. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 2007; 119: 1303-1310. .
 
17.
Lhote F. Churg-Strauss syndrome. Presse Med 2007; 36: 875-889. .
 
18.
Watts RA, Carruthers DM, Scott DG. Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum 1995; 25: 28-34. .
 
19.
Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-1100. .
 
20.
Chang TW, Wu PC, Hsu CL, Hung AF. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases. Adv Immunol 2007; 93: P63-119.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top